What happened
Bukwang Pharmaceutical IND updated a previously disclosed supply contract, now worth US$10.4M, about 10.47% of its recent annual revenue, running through Mar 2027.
For context, this single contract equals about 10.47% of the company's most recent annual revenue.
| Counterparty | Disclosed |
|---|---|
| Contract value | US$10.4M |
| vs. recent revenue | 10.47% |
| Through | Mar 2027 (from Mar 2016) |
| Filed | 2026-02-27, [Amended] Supply contract signed |
| Source | DART rcept 20260227801343 → open original filing |
Source: DART. Information only, not investment advice.